The DOI matches its Crossref record.
Do Pharmaceutical Sales Respond to Scientific Evidence?
Abstract
I investigate how different sources of information influence the diffusion of pharmaceutical innovations. In prescription‐drug markets, both advertising and scientific information stemming from clinical trials can affect physicians' prescription choices. Using novel indices of clinical‐research output, I find that both marketing and scientific evidence directly influence the diffusion process in the antiulcer‐drug market, with marketing having a more pronounced influence. I also find evidence that clinical outputs are important drivers of firms' marketing efforts, affecting sales indirectly. Taken together, the direct and indirect effects of science on demand imply strong private incentives for clinical research. I conclude that product‐market competition in the pharmaceutical industry is shaped by both advertising rivalries and scientific rivalries. Moreover, drug advertising may perform an important informative function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform
Kesselheim, A. S., Avorn, J., & Sarpatwari, A. (2016) · JAMA · doi:10.1001/jama.2016.11237 · Cited by 592
Spurling, G. K., Mansfield, P. R., Montgomery, B. D., Lexchin, J., Doust, J., Othman, N., & Vitry, A. I. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000352 · Cited by 526
The decline of science in corporate R&D
Arora, A., Belenzon, S., & Patacconi, A. (2018) · Strategic Management Journal · doi:10.1002/smj.2693 · Cited by 330
Knowledge Spillovers and Corporate Investment in Scientific Research
Arora, A., Belenzon, S., & Sheer, L. (2021) · American Economic Review · doi:10.1257/aer.20171742 · Cited by 329
Metadata
- Authors
- Azoulay, P.
- Venue
- Journal of Economics & Management Strategy
- Publisher
- Wiley
- Published
- 2002-12
- Volume
- 11
- Issue
- 4
- Pages
- 551-594
- ISSN
- 1058-6407 (ISSN-L)
- 1530-9134
- OpenAlex
- W2126907752
- Cited by
- 198
- References
- 0
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do Pharmaceutical Sales Respond to Scientific Evidence? https://app.cochat.ai/papers/10.1111/j.1430-9134.2002.00551.x
- The paper
- Azoulay, P. (2002). Do Pharmaceutical Sales Respond to Scientific Evidence? Journal of Economics & Management Strategy. https://doi.org/10.1111/j.1430-9134.2002.00551.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.